697 research outputs found
Recent Legislation: Securities Act of 1933--Rule Modification--The No-Sale Rule and the Privilege to Avoid Registration [\u3ci\u3eSecurities Act Rule 133(a)\u3c/i\u3e, 17 CFL § 230.133(a). (1968), \u3ci\u3eas amended\u3c/i\u3e, SEC Securities Act Release No. 4892, 33 Fed. Reg. 566 (1968)]
Reforming Electric Utility Rate Regulation Reform: Peak-Load Prices without Long-Run Incremental Cost Analysis
Recent Legislation: Securities Act of 1933--Rule Modification--The No-Sale Rule and the Privilege to Avoid Registration [\u3ci\u3eSecurities Act Rule 133(a)\u3c/i\u3e, 17 CFL § 230.133(a). (1968), \u3ci\u3eas amended\u3c/i\u3e, SEC Securities Act Release No. 4892, 33 Fed. Reg. 566 (1968)]
Reforming Electric Utility Rate Regulation Reform: Peak-Load Prices without Long-Run Incremental Cost Analysis
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study
Pyruvate kinase (PK) deficiency is the most common red cell glycolytic enzyme defect causing hereditary non-spherocytic hemolytic anemia. Current treatments are mainly supportive and include red cell transfusions and splenectomy.11 Regular red cell transfusions are known to result in iron overload; however, the prevalence and spectrum of transfusion-independent iron overload in the overall PK deficient population has not been well defined. This analysis describes the prevalence and clinical characteristics of iron overload in patients enrolled in the PK Deficiency Natural History Study (NHS) with a focus on those patients who are not regularly transfused.
- …